Skip to content

Absci Corp

US · ABSI #2817 by market cap Listed 2021
7.51 -0.65 -7.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Absci Corp

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Founded
2011
CEO
Mr. Sean McClain
Employees
140
Headquarters
Vancouver, Washington, United States of America
Fiscal year end
12-31
Website
absci.com

Company profile

Exchange
US
Symbol
ABSI
Market-cap rank
#2817
Listing date
2021-07-22
Market cap
1.30B
Float cap
1.24B
Shares out
172.75M
Float shares
164.74M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

Absci Corp discussion 0 comments

Add a comment